Table 1 Characteristics of patients at diagnosis
|  | Overall (n = 56) |
|---|---|
Male | 28 (50.0) |
Female | 28 (50.0) |
Median age at diagnosis (IQR) [years] | 68 (9.5) |
Comorbidities | Â |
 Chronic pancreatitis | 9 (16.1) |
 Diabetes | 8 (14.3) |
Detection | Â |
 Incidental finding | 44 (78.6) |
 Abdominal pain | 7 (12.5) |
 Pancreatitis | 5 (8.9) |
Mode of detection | Â |
 CT | 46 (82.2) |
 MRI | 7 (12.5) |
 US | 3 (5.4) |
BD-IPMN | 41 (73.2) |
MD-IPMN | 9 (16.1) |
MT-IPMN | 6 (10.7) |
Localization of IPMN1 | Â |
 Head | 22 (39.3) |
 Body | 15 (26.8) |
 Uncinated process | 14 (25.0) |
 Tail | 9 (16.1) |
 Neck | 8 (12.3) |
Median cyst size at diagnosis (IQR) [mm] | 16.0 (13) |
MPD-size 3.5–5 mm | 10 (17.9) |
WF at diagnosis (WF +) 2 | 15 (26.8) |
 Cyst size ≥ 3 cm | 9 |
 Thickened or enhancing cyst walls | 2 |
 MPD-size 5–9 mm | 8 |
 Recurrent pancreatitis | 2 |
HRS at diagnosis (HRS +)2 | 3 (5.6) |
 Obstructive jaundice | 1 |
 High-grade dysplasia on EUS-FNA | 2 |